A Survivor and Lymphoma Wristbands
Today I read the story of "Grandpa Pat", who is Pat Daulton, a Mantle Cell Non-Hodgkin's Lymphoma (NHL) survivor. To help in the cause in supporting the children helped by Pat over the years and lymphoma research, Pat and Renee Daulton formed the Daulton Foundation.
They also sponsor "Hugs Heal" blue wristbands. Supposedly the foundation has sold more than 500 wristbands, which cost $10 and benefit the Lymphoma Research Foundation and the Exercise Medicine Center.
Given the article and the site, it all seems genuine but before shelling out I suggest you dig a bit more to see how much money goes where (like they say about tsunami charities). Although these have a "negative ion" capability the yellow Lance Armstrong bands don't have, $10 is more than $1.
I have no connection with the Daulton Foundation.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
